cordycepin has been researched along with Osteoarthritis, Knee in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Gu, HY; Lian, DB; Liu, PF; Tao, WW; Tao, XM; Yan, D; Zhao, B | 1 |
| Bao, J; Chen, W; Hu, P; Jiang, L; Wu, L | 1 |
2 other study(ies) available for cordycepin and Osteoarthritis, Knee
| Article | Year |
|---|---|
Cordycepin Alleviates Anterior Cruciate Ligament Transection (ACLT)-Induced Knee Osteoarthritis Through Regulating TGF-β Activity and Autophagy.
Topics: Animals; Anterior Cruciate Ligament; Autophagy; Deoxyadenosines; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Injections, Intravenous; Male; Medicine, Chinese Traditional; Osteoarthritis, Knee; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2020 |
Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Deoxyadenosines; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glycosaminoglycans; Humans; Inflammation Mediators; Interleukin-1beta; Metalloproteases; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis, Knee; Severity of Illness Index | 2014 |